SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Shawn Murphy who wrote (2044)1/15/1997 7:52:00 PM
From: garden_man   of 2281
 
Shawn,

I consider you a very savory trader. I been on your thread and you seem you know what your talking about. I do know of Knight, Sherwood, and Mash, but if these dealers are your sources, Ah-Yah-Yah. Are you telling me that MM's are going to give you straight poop about ADVR or for that matter any other stock out there in BB land.

God you must know the only interest they have at heart is thier own. I have been trading BB stock since 1981 and I can tell I have never run across a broker, dealer or MM that has been on the up and up.

If they have excess inventory on a stock they are going to talked it up. If they are short on a stock they are going to talk it down.

When I was dealing directly with the market marker in my early days of trading, the only advantage I had was that I was paying no commission, but little did I know that they were making their buck-a-roos on the spread.

Now I am dealing with Dean Witter on my long term investments and Etrade and PCFN with my speculative stuff. But even my broker at DW has his best interest in mind. He recently recommended Staples to me and I bought about 500 shares, but I can tell you that his pit bull had an inventory they had to unload.

As far as IR at ADVR, it does not exist (this has always been a major problem with them). So I don't know with whom you are talking with.

I can tell you one thing. "R" is for real. I/ve got about 1000 pages of documentation I have aquired over the years to prove it. Email me and I will glading discuss getting this material to you.

What most of the naysayers don't get is that most of us invested in "R" not ADVR. I spoke with a couple fellow investors over the weekend to help me draft the letter. Between the four of us, we control about 1.2m shares. Three of us have been in the stock just about from the beginning.

Each of us fully realize that "R" is a organic compound that has about a dozen applications tied up with a company that has been managed poorly and has not had a sound marketing or business plan. Has this change with the appointment of Dr "H", don't know thats why I fired off a letter. Will the letter do any good, don't know.

We are in this for one thing and one thing only see that "R" comes back on the market. Thats why our investment has not left ADVR. If ADVR is the company that accomplishes that task or someone else that does not matter, the results will be the same. HUGE RETURN ON MY INVESTMENT and a compound that will impact the medical community in a big way.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext